Mimetic Solutions Gets UT Technology License, Funding

The University of Texas, Austin announced Wednesday that Austin, Texas-based Mimetic Solutions has licensed drug delivery technology developed by a UT Austin team, and also received funding from the Emergent Technologies Fund IV. The new firm, which is headed by Dr. Nicholas Peppas, will focus on drug delivery and smart release chemistry. The Emergent Technologies Fund IV is a early stage fund focused on commercialization technologies from the The University of Texas System. More information »